Home » Topics » Medical technology

Medical technology
RSS

Genelabs Enters $55M Deal With Watson For Lupus Drug Aslera

Nov. 14, 2000

Immunex Raises $795M Publicly While AHP Reduces Ownership

Nov. 13, 2000

Wide-Ranging Neural Stem Cells, Aping Glioblastomas, Delivered Antitumor Drugs To Mice, Rats

Nov. 13, 2000

Other News To Note

Nov. 13, 2000

FDA Submissions, Approvals And Other Actions: October 2000

Nov. 13, 2000

Clinical Trial Update: October 2000

Nov. 13, 2000

Investor Payoffs Unlikely Soon From Alzheimer's Disease Drugs

Nov. 13, 2000

NPS Brings In $168M After Adding Shares To Offering

Nov. 13, 2000

OGT Scores A Point In Array Patent Battle With Affymetrix

Nov. 13, 2000

bf11132000e.html

Nov. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...